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a synthetic acylphytosphingolipid originally isolated
from a marine sponge (Kawano et al., 1997; Spada et
al., 1998).
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al., 1995; Behar et al., 1999). CD1d-restricted T cells
have also been associated with various immunologicallyNKT cells are associated with immunological control
mediated functions, such as preventing development ofof autoimmune disease and cancer and can recognize
autoimmune diabetes, tumor rejection, and modulatingcell surface mCD1d without addition of exogenous
IgG responses during protozoal infections (Cui et al.,antigens. Cellular antigens presented by mCD1d have
1997; Wilson et al., 1998; Schofield et al., 1999).not been identified, although NKT cells can recognize
The origin and the identity of the natural antigensa synthetic glycolipid, a-GalCer. Here we show that
recognized by CD1d-restricted T cells remain unknown.after addition of a lipid extract from a tumor cell line,
It has been postulated that mCD1d-restricted NKT cellsplate-bound mCD1d molecules stimulated an NKT cell
may recognize a single or a conserved set of antigens,hybridoma. This hybridoma also responded strongly
since their cannonical a chains and limited b chain diver-to three purified phospholipids, but failed to recognize
sity result in TCRs of comparatively little structural vari-
a-GalCer. Seven of sixteen other mCD1d restricted
ability, whereas the diverse TCR population of mCD1d-hybridomas also showed a response to certain purified
restricted T cells may have heterogeneous antigenicphospholipids. These findings suggest NKT cells can
specificities (Cardell et al., 1995; Behar et al., 1999; Chiu
recognize cellular antigens distinct from a-GalCer and
et al., 1999). Both T cell populations can recognize CD1d
identify phospholipids as potential self-antigens pre- molecules on antigen-presenting cells (APCs) in vitro,
sented by mCD1d. without requiring addition of exogenous antigens (Ben-
delac et al., 1995; Behar et al., 1999). Whether this phe-
Introduction
nomenon is due to recognition of the CD1d heavy chain
itself or represents recognition of CD1d complexed with
CD1 molecules are evolutionarily conserved b2-micro- cellular antigens or exogenous antigens derived from
globulin (b2m)-associated proteins, with a similar do- the culture medium is unclear. NKT cells have also been
main organization to class I antigen-presenting mole- shown to respond to synthetic a-GalCer in a CD1d de-
cules of the major histocompatibility complex (Porcelli, pendent manner, but this antigen has thus far not been
1995). However, CD1 molecules have a deeper and more found in mammalian tissues (Kawano et al., 1997).
hydrophobic antigen-binding groove than class I mole- Hence, neither the nature of the cellular antigens bound
cules (Zeng et al., 1997). Correspondingly, while class I by CD1d molecules nor whether these antigens are re-
molecules present peptide antigens, CD1 molecules can quired for T cell recognition of CD1d molecules is well
present lipids and glycolipids. Studies of human CD1a, understood.
-b, and -c molecules first demonstrated that they can Here, we investigated the requirement for presenta-
present microbial glycolipid antigens to T cells (Beck- tion of cellular antigens in T cell recognition of mCD1d
man et al., 1994, 1996; Sieling et al., 1995). Subse- molecules and examined the antigen specificities of
quently, both human and murine CD1d molecules have mCD1d-restricted T cells of the NKT cell and diverse
been shown to present a-glactosylceramide (a-GalCer), TCR populations. We developed a system to study rec-
ognition of mammalian lipids using an immobilized mu-
rine CD1d fusion protein and purified antigen prepara-§ To whom correspondence should be addressed (e-mail: sbehar@
rics.bwh.harvard.edu). tions. Recognition of the recombinant mCD1d fusion
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protein in this system was dependent on the addition of
particular lipids, permitting analysis of the lipid antigen
specificities of mCD1d-restricted T cells. Our results
provide evidence that mCD1d-restricted T cells require
presentation of specific antigens for recognition of
mCD1d molecules. Surprisingly, our findings suggest
that the mCD1d-restricted NKT cell subset surveys mul-
tiple cellular antigens distinct from a-GalCer and impli-
cate common phospholipids as potential autoantigens
recognized by certain NKT cells.
Results
An mCD1d-Restricted NKT Cell Hybridoma Responds
to a Lipid Extract from RMA-S Cells
Certain mCD1d-restricted T cells do not require exoge-
nous antigens for mCD1d recognition, suggesting that
they may recognize mCD1d molecules directly or may
recognize cellular antigens complexed with mCD1d
(Bendelac et al., 1995; Behar et al., 1999). To investigate
whether cellular lipids are involved in such recognition,
we studied an NKT cell clone called 24.8, which recog-
nizes mCD1d expressed on murine splenocytes and
dendritic cells as well as on mCD1d-transfected RMA-S
tumor cells (Behar et al., 1999; S. M. B., unpublished
data). Because hybridomas can produce IL-2 in re-
sponse to antigenic stimulation in the absence of addi-
tional costimulatory signals, a T cell hybridoma, desig-
nated 24.8.A, was derived from this clone.
To investigate mCD1d recognition by the 24.8.A hy-
bridoma, we tested a soluble mCD1d-IgGFc2a fusion
protein that had been purified and immobilized on pro-
tein A±coated plates for its ability to stimulate IL-2 re- Figure 1. IL-2 Secretion by the 24.8.A Hybridoma in Response to
lease. The 24.8.A hybridoma usually secreted a modest Plate-Bound mCD1d Molecules and Antigens Extracted from Tumor
Cell Linesamount of IL-2 when incubated with the mCD1d fusion
(A) The mCD1d fusion protein (mCD1d-Fc) or a negative controlprotein (50±300 pg/ml in 60% of the experiments), but
protein (neg control), pretreated with buffer (no Ag), or 3.3 mg/wellit occasionally produced high levels of IL-2 (.600 pg/
of the aqueous, interface, or organic phase fractions from a Folchml in 20% of the experiments) or did not generate quanti-
extraction of RMA-S tumor cells.fiable IL-2 (20% of the experiments; data not shown).
(B) The mCD1d fusion protein preincubated with serially diluted
In contrast, incubation with an immobilized anti-CD3 amounts of the organic phase of a Folch extraction of RMA-S cells.
mAb consistently resulted in very high levels of IL-2 Open circles, assays performed without added antibody; filled cir-
cles, assays performed in the presence of a negative control anti-secretion (usually .2000 pg/ml IL-2; data not shown).
class II MHC mAb; filled squares, assays performed in the presenceNo detectable IL-2 was secreted when the 24.8.A hybrid-
of the 19G11 anti-mCD1d mAb.oma was incubated with a negative control protein (IgG2a
(C) The mCD1d fusion protein preincubated with serially dilutedmAb RPC5.4 or UPC10) immobilized on the protein A
fractions eluted from a silica column after passage of an organic
plate (data not shown). extract of S49 tumor cells. Open circles, unfractionated organic
The poor stimulation of the 24.8.A hybridoma by the extract; filled diamonds, chloroform eluate; filled squares, acetone
eluate; filled triangles, methanol eluate. The data represent the meanmCD1d fusion protein suggested that a specific cellular
OD405 nm or the pg/ml IL-2 detected in an IL-2 ELISA of hybridomaantigen might be required for efficient recognition of the
culture supernatants from three replicate wells. Error bars show therecombinant mCD1d molecule. We reasoned that an
standard deviations of the means.appropriate antigen should be contained within a lipid
extract made from RMA-S cells, since these cells can
be efficiently recognized when they are transfected with with the organic phase of the RMA-S extract resulted
in markedly augmented IL-2 release by the 24.8.A hy-mCD1d (Behar et al., 1999). A modified Folch extraction
protocol was used to purify biochemical fractions from bridoma compared to the mCD1d fusion protein treated
with buffer (Figure 1A). In contrast, the mCD1d fusionRMA-S and S49 T lymphoma cells (Folch et al., 1956;
Hamilton et al., 1992). The resulting aqueous, organic, protein preincubated with the interface induced only a
small increase in IL-2 production, and treatment withand interface fractions were tested for the ability to stim-
ulate the 24.8.A hybridoma. Plate-bound mCD1d fusion the aqueous phase did not enhance IL-2 secretion com-
pared to the buffer-treated control (Figure 1A). The nega-protein or the negative control protein was preincubated
with the cellular fractions, then repeatedly washed to tive control protein failed to induce significant IL-2
secretion when preincubated with any of the Folch frac-remove unbound material prior to addition of the 24.8.A
hybridoma. Pretreatment of the mCD1d fusion protein tions (Figure 1A). Thus, stimulation was dependent on
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the presence of the mCD1d fusion protein and specific slightly enhanced response to the mCD1d fusion pro-
tein, which had been preincubated with the a-GalCerfor the organic phase of the cellular extract, which con-
antigen or the other sphingolipids, compared to un-tains mainly the cellular lipids (Folch et al., 1956; Hamil-
treated fusion protein (Figure 2A). However, pretreat-ton et al., 1992).
ment of the mCD1d fusion protein with PI resulted inTo examine further the antigen dependence of the
a marked increase of IL-2 production (Figure 2A). Inhybridoma, the amount of organic extract added to the
contrast, the 24.9.E hybridoma responded strongly toplate-bound mCD1d fusion protein was titrated. Titra-
the mCD1d fusion protein, which had been preincubatedtion of the lipid extract from 0.03 mg/well to 10 mg/well
with a-GalCer, but showed only modestly increased IL-2produced a dose-dependent response that appeared
secretion in response to the PI-treated mCD1d fusionsaturated at 1 mg/well (Figure 1B). In the presence of a
protein (Figure 2A). Consistent with the results of Ka-negative control anti-MHC class II mAb, the titration
wano et al. (1997), stimulation of the 24.9.E NKT cellcurve was nearly identical, but an anti-mCD1d blocking
hybridoma required the a-linked galactose to be presentmAb completely abrogated the response (Figure 1B).
on the galactosylceramide antigen, since neither the un-Organic extracts from S49 cells gave similar results (data
glycosylated ceramide nor the closely related b-linkednot shown). Hence, the lipid fraction of mammalian cellu-
form, b-GalCer, was recognized (Figure 2A). The asialo-lar extracts contained antigenic material that stimulated
GM2 sphingolipid also was not recognized (Figure 2A).the 24.8.A hybridoma in an mCD1d- and dose-depen-
Pretreatment of the negative control protein with any ofdent manner.
the lipids failed to induce detectable IL-2 secretion byTo characterize the nature of the antigen contained in
either hybridoma (data not shown). Thus, while thethe cellular lipid extract, the organic phase preparations
24.8.A. and 24.9.E hybridomas both required additionfrom the Folch extractions were further fractionated us-
of a lipid antigen to the mCD1d fusion protein for efficienting a silica column. Lipids of increasing polarity were
activation, they appeared to have distinct antigen speci-eluted sequentially from the column with chloroform,
ficities.acetone, and methanol, resulting in separation of frac-
Titration of the molar ratio of antigen to fusion proteintions that predominantly contained neutral lipids, glyco-
from 10:1 to 80:1 confirmed the antigen-specific, dose-lipids, and phospholipids, respectively. These fractions
dependent responses of the 24.8.A and 24.9.E hybrid-were tested for stimulation of the 24.8.A hybridoma,
omas (Figure 2B). IL-2 production by the 24.8.A hybrid-compared to the unfractionated organic phase of the
oma appeared saturated at a 40:1 molar ratio of PI toextract, by titrating the amount of each fraction preincu-
mCD1d fusion protein, while little IL-2 was secreted evenbated with the plate-bound mCD1d fusion protein. Addi-
at an 80:1 molar excess of a-GalCer (Figure 2B). In con-tion of the chloroform fraction did not induce detectable
trast, the 24.9.E hybridoma secreted IL-2 efficiently inIL-2 production (Figure 1C). In contrast, pretreatment of
response to a-GalCer-treated mCD1d fusion protein butthe mCD1d fusion protein with the acetone and metha-
generated significantly less IL-2 even at high ratios ofnol fractions resulted in dose-dependent stimulation of
PI to mCD1d (Figure 2B). To confirm that this antigen-the 24.8.A hybridoma (Figure 1C). Hence, the 24.8.A
dependent stimulation of the NKT cell hybridomas washybridoma recognized fractions of the organic extract
mCD1d specific, the 19G11 anti-mCD1d blocking anti-containing polar lipids but did not respond to a fraction
body was used. In a representative experiment, theenriched in neutral lipids.
24.8.A hybridoma secreted a mean of 4746 pg/ml IL-2
in response to mCD1d fusion protein pretreated with PI,
Recognition of Synthetic Antigens by NKT but in the presence of the 19G11 mAb, no detectable IL-2
Cell Hybridomas was produced. For the 24.9.E hybridoma, pretreatment
Studies using human cells have shown that CDI mole- with a-GalCer resulted in production of a mean of 2089
cules present lipid antigens, including mycolic acids and pg/ml IL-2, which was reduced to 103 pg/ml when the
the glycosylated phosphatidylinositols (GPIs) lipoarabi- 19G11 anti-mCD1d mAb was included. Hence, antigen-
nomannan and phosphatidyl mannoside (Beckman et specific activation of the hybridomas by the mCD1d
al., 1994; Sieling et al., 1995). Subsequently, GPI and fusion protein could be blocked by addition of an anti-
the acylphytosphingolipid a-GalCer have been shown mCD1d antibody.
to bind and be presented by murine CD1d (Kawano et
al., 1997; Joyce et al., 1998; Schofield et al., 1999). Our Specificity of Phospholipid Antigen Recognition
finding that addition of cellular organic extracts con- To examine the specificity of PI recognition by the 24.8.A
taining polar lipids permitted efficient recognition of the hybridoma, analogs of PI were tested with the mCD1d
mCD1d fusion protein suggested that the 24.8.A hybrid- fusion protein. Three synthetic PIs with one, two, or
oma recognizes an abundant mammalian lipid. To inves- three additional phosphate groups attached to carbons
tigate recognition of potential cellular lipid antigens, we of the inositol ring (PI3-P, PI3,4-P2, and PI3,4,5-P3, re-
tested a purified preparation of the phospholipid phos- spectively) were compared to PI and to successively
phatidylinositol (PI) and a series of purified and syn- smaller constituent components of PI: phosphatidic acid
thetic sphingolipids for recognition by the 24.8.A hybrid- (PA), which lacks the inositol ring of PI; diacyl glycerol
oma and by another NKT cell hybridoma called 24.9.E. (DAG), which lacks the phosphate of PA; palmitic acid,
Plate-bound mCD1d fusion protein or a negative control which corresponds to one free acyl chain of the DAG
protein was pretreated with a-GalCer, b-GalCer, ungly- molecule; and free inositol. As previously observed, pre-
cosylated ceramide, the naturally occurring gangliotrio- treatment of the mCD1d fusion protein with PI resulted
syl-ceramide (asialo-GM2), and PI prior to addition of in significantly enhanced IL-2 release (Figure 3A). Treat-
ment of the fusion protein with components of PI lackingthe hybridomas. The 24.8.A hybridoma showed only a
Immunity
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Figure 2. IL-2 Secretion by the 24.8.A and
24.9.E Hybridomas in Response to Plate-
Bound mCD1d Molecules and Purified or
Synthetic Lipid Antigens
(A) The mCD1d fusion protein incubated with
buffer (no Ag), a-GalCer (aGC), b-GalCer
(bGC), unglycosylated ceramide (Cer), asialo-
GM2 ganglioside (aGM2), or phosphatidylino-
sitol (PI).
(B) The mCD1d fusion protein incubated with
serially diluted amounts of a-GalCer (open
squares) or PI (filled circles). The data repre-
sent the mean pg/ml IL-2 detected in hybrid-
oma culture supernatants from three repli-
cate wells. Error bars show the standard
deviations of the means.
the inositol ring attached to the acyl chains (PA, DAG, demonstrated dose-dependent responses to the PE and
PG antigens, which appeared saturated at a molar ratiopalmitate, and inositol) provided little or no stimulation
(Figure 3A). IL-2 secretion induced by pretreatment with of 40:1 antigen to fusion protein (Figure 3C). Preincuba-
tion with PC or PS did not reproducibly significantlythe synthetic phosphorylated PI antigens was also sig-
nificantly greater than that for the mCD1d fusion protein enhance reactivity to the mCD1d fusion protein (Figure
3C). Hence, recognition of the mCD1d fusion protein byincubated with buffer alone (Figure 3A). These results
suggested that the inositol ring was an important anti- the 24.8.A hybridoma was clearly augmented by pre-
treatment with PI, PE, and PG but not with PS or PC.genic determinant of PI for the 24.8.A hybridoma.
To confirm the importance of the inositol ring in recog- Taken together these results are consistent with a model
in which the acyl chains of the lipid tails are requirednition of PI, the PI was phospholipase treated prior to
incubation with the fusion protein. Two different phos- for binding to CD1 molecules, but antigen specificity is
determined by TCR recognition of features of the polarpholipases were tested. Phospholipase D (PLD) re-
moves the inositol ring from the phosphate, which links head group (Porcelli and Brenner, 1997).
it to the diacyl glycerol backbone, to yield free inositol
and phosphatidic acid (PA). PI-specific phospholipase The Effect of pH on Antigen Recognition
Previous studies have suggested that CD1d moleculesC (PI-PLC) cleaves the bond between the phosphate and
the glycerol to produce inositol phosphate and diacyl may encounter antigens in intracellular vesicles that un-
dergo substantial acidification during the process ofglycerol (DAG). Treatment of PI with PLC or PLD prior
to preincubation of the antigen with the mCD1d fusion antigen loading (Kawano et al., 1997; Brossay et al.,
1998; Spada et al., 1998; Chiu et al., 1999). The 24.9.Eprotein reduced IL-2 secretion by approximately 70%,
approaching the IL-2 levels seen when synthetic prepa- hybridoma was used to examine the effect of acidic pH
on a-GalCer presentation by the mCD1d fusion protein.rations of DAG or PA were incubated with the fusion
protein (Figure 3B). Thus, the inositol ring appears to be The mCD1d fusion protein was incubated with a-GalCer
antigen diluted into citrate/phosphate buffer solutionsimportant for PI recognition by the 24.8.A hybridoma in
this system, and forms of PI that are phosphorylated on ranging from pH 7.5 to pH 3.0 at a 3:1 molar ratio of
antigen to protein; the solutions were then neutralizedthe inositol ring can also be recognized.
We next examined the specificity of the 24.8.A hybrid- to allow binding to the protein A±coated plate and as-
sayed for recognition by the 24.9.E hybridoma (Figureoma for PI compared to other common phospholipid
antigens. Four additional phospholipids related to PI 4). Recognition of the a-GalCer antigen was enhanced
approximately 4-fold after antigen preincubation at pHwere tested: phosphatidylcholine (PC), phosphatidyl-
ethanolamine (PE), phosphatidylglycerol (PG), and phos- 4.0 compared to pH 7.5. Maximal IL-2 release was repro-
ducibly observed for the samples preincubated at pHphatidylserine (PS). Titrations of the molar ratio of anti-
gen to fusion protein from 10:1 to 80:1 were carried out 4.0, while IL-2 production dropped significantly for sam-
ples preincubated below this pH (Figure 1F). Negativefor these antigens (Figure 3B). The 24.8.A hybridoma
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Figure 4. Analysis of the Effect of the Buffer pH during a-GalCer
Preincubation with the mCD1d Fusion Protein on Stimulation of the
24.9.E Hybridoma
Plots represent the mean pg/ml IL-2 detected in hybridoma culture
supernatants from six replicate wells. Error bars show the standard
deviation of the mean.
preincubation at low pH did not affect binding of the
fusion protein to the protein A plate, the assay plate
was tested (after removal of the culture supernatants)
for the presence of mCD1d using a biotinylated rat anti-
mCD1d mAb (19G11), which does not bind to protein
A, followed by detection with a streptavidin-enzyme
conjugate and a chromogenic substrate. This analysis
revealed that the amount of mCD1d fusion protein
bound to the plate was not affected by the preincubation
pH (data not shown). Therefore, although antigens incu-
bated at physiological pH could be recognized, treat-
ment of the mCD1d fusion protein with a-GalCer at pH
4.0 provided optimal antigen recognition in this system.
Comparison of Antigen Recognition by Diverse
and NKT Cell mCD1d-Restricted Hybridomas
Our observation that two NKT cell hybridomas, 24.8.A
and 24.9.E, differed in their antigen reactivity raised the
possibility that NKT cells may have heterogeneous anti-
gen specificities. To extend our analysis of NKT cells and
to compare antigen recognition by mCD1d-restricted T
cells of the diverse TCR population, we tested 9 NKTFigure 3. IL-2 Secretion by the 24.8.A Hybridoma in Response to
Plate-Bound mCD1d Molecules and Purified or Synthetic Phospho- and 8 diverse TCR mCD1d-restricted hybridomas for
lipids and Analogs recognition of 14 purified and synthetic lipid antigens
(A) The mCD1d fusion protein preincubated with buffer (none), phos- (see Tables 1 and 2). None of the hybridomas produced
phatidylinositol (PI), phosphorylated phosphatidylinositols (PI3-P; detectable IL-2 in response to a negative control protein,
PI3,4-P2; PI3,4,5-P3), phosphatidic acid (PA), diacyl glycerol (DAG), and only the 24.8.A hybridoma secreted detectable IL-2
palmitic acid (palmitate), or free inositol (inositol).
in response to untreated mCD1d fusion protein (Table(B) The mCD1d fusion protein preincubated with untreated phospha-
2). Eight out of nine NKT cell hybridomas were potentlytidylinositol (PI), PI-specific phospholipase C treated PI (PI-PLC),
stimulated by a-GalCer-treated fusion protein, whereasphospholipase D treated PI (PLD), diacyl glycerol (DAG), or phospha-
tidic acid (PA). none of the diverse TCR hybridomas reproducibly rec-
(C) The mCD1d fusion protein preincubated with serially diluted ognized this antigen (Table 2). Purified PI strongly stimu-
amounts of phosphatidylethanolamine (PE), phosphatidylglycerol lated the 24.8.A hybridoma and also stimulated some
(PG), phosphatidylserine (PS), or phosphatidylcholine (PC). The data
of the a-GalCer reactive NKT cell hybridomas, althoughrepresent the mean pg/ml IL-2 detected in hybridoma culture super-
with only about 10%±20% of the activity of the syntheticnatants from three replicate wells. Error bars show the standard
a-GalCer. Several diverse TCR hybridomas also se-deviations of the means.
creted detectable IL-2 upon incubation with PI-, PE-, or
PG-treated mCD1d fusion protein (Table 2). None of the
hybridomas reproducibly recognized any of the othercontrol wells containing the mCD1d fusion protein di-
luted into the pH-titrated citrate/phosphate buffer solu- antigens tested. Thus, in this antigen screen, most
(8/9) of the NKT cell hybridomas recognized a-GalCer,tions with no antigen added or a negative control protein
treated with a-GalCer at pH 7.2 did not induce detect- whereas all but one of the diverse TCR hybridomas failed
to respond to this antigen. In contrast, approximatelyable IL-2 production (data not shown). To ensure that
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differences in the abilities of CD1d-restricted T cells toTable 1. TCR Gene Usage of TT Hybridoma Cells Used for
recognize different APCs, indicating that different APCsAnalysis
may present distinct antigens, and CD1d-restricted T
Hybridoma Lineage Va/Ja Genes Vb/Jb Genes cell clones may have heterogeneous antigen specifici-
24.8.A NKT Va14/Ja281 Vb8.2/Jb2.5 ties (Brossay et al., 1998; Couedel et al., 1998; Park et
24.7.C NKT Va14/Ja281 Vb6.1/Jb2.6 al., 1998; Chiu et al., 1999). Therefore, to investigate
24.9.E NKT Va14/Ja281 Vb8.3/Jb2.4 whether the antigen specificities of the hybridomas in
DN32D3 NKT Va14/Ja281 Vb8.2/Jb2.4
the mCD1d fusion protein plate stimulation assay corre-KT/7 NKT Va14/Ja281 Vb8.2/ND
late with their ability to recognize mCD1d expressed byKT/12 NKT Va14/Ja281 Vb8.2/ND
cells, we tested the panel of hybridomas for recognitionKT/22 NKT Va14/Ja281 Vb8.2/ND
KT/23 NKT Va14/Ja281 Vb8.2/ND of four different mCD1d-transfected tumor cell lines:
Vb/9 NKT Va14/Ja281 Vb8.2/ND RMA-S and EL-4 are derived from T lymphomas, A20
14S.6.A diverse Va17.1/JaTT11 Vb14.1/Jb2.1 from a B lymphoma, and P815 from a mastocytoma.
14S.7.N diverse Va15.1/JaNEW.02 Vb8.2/Jb2.5 The hybridomas were incubated with the mCD1d-trans-
14S.10.C diverse Va11.3/JaNEW.15 Vb8.1/Jb2.6
fected tumor cell lines or the untransfected parental14S.15.A diverse Va10.2/9/JaTA65 Vb5.1/Jb2.4
lines without addition of exogenous antigens. The un-VII68 diverse Va4/Ja25 Vb11/Jb2.5
transfected tumor cells stimulated little or no detectableVIII24 diverse Va3.2/Ja20 Vb9/Jb1.4
XV19 diverse ND ND IL-2 release by any of the hybridomas (data not shown),
XV104 diverse Va4/5/ND Vb8.3/Jb2.6 whereas the mCD1d-transfected cells could induce high
levels of IL-2 secretion by certain NKT and diverse TCRTCR a and b gene usage for the 24.7.C, 24.8.A, 24.9.E, DN32D3,
14S.6.A, 14S.7.N, 14S.10.C, 14S.15.A, VII68, VIII24, and XV104 hy- hybridomas (Table 3).
bridomas was determined by DNA sequencing. For the KT/7, KT/ Surprisingly, despite their common specificity for
12, KT/22, KT/23, and Vb/9 hybridomas, the presence of the Va14/ a-GalCer-treated mCD1d fusion protein, there were
Ja281 rearranged TCR a chain was determined by PCR analysis, three distinct patterns of recognition of the mCD1d-
and the Vb chain usage was assessed by flow cytometry.
transfected cell lines among the eight a-GalCer-reactive
NKT lineage hybridomas (Table 3). The a-GalCer-reac-
tive 24.7.C hybridoma recognized all of the mCD1d-
half of both the NKT and diverse TCR hybridomas tested expressing cells well (.500 pg/ml IL-2 release for each
showed some reactivity to certain phospholipid antigens. transfectant), while the 24.9.E, DN32D3, and KT/23 hy-
bridomas only responded to the mCD1d-transfected
Recognition of mCD1d-Transfected Tumor EL-4 cell line (Table 3). The remaining four a-GalCer-
Cell Lines reactive hybridomas, KT/7, KT/12, KT/22, and Vb/9,
The results of our analyses using the mCD1d fusion showed little or no recognition of any of the mCD1d-
protein suggested mCD1d-restricted T cells may require transfected cells (Table 3). The 24.8.A hybridoma, which
presentation of specific antigens for recognition of had specificity for phospholipids rather than a-GalCer,
responded well to all of the transfected cell lines (TablemCD1d molecules. Previous studies have demonstrated
Table 2. mCD1d-Restricted Hybridoma Responses to Plate-Bound mCD1d Fusion Protein Preincubated with Lipid Antigens
Invariant TCRa NKT Hybridomas Diverse TCR Hybridomas
24.8.A 24.7.C 24.9.E DN32D3 KT/7 KT/12 KT/22 KT/23 Vb/9 14S.6.A 14S.7.N 14S.10.C 14S.15.A VII68 VIII24 XV19 XV104
No mCD1d 0 0 0 0 0 0 0 0
No Ag 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
a-GalCer 1 111 111 111 111 111 111 111 11 0 0 0 1 0 0 0 0
b-GalCer 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cer 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sph 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
aGM2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
GD1a 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PA 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PI 111 0 1 0 0 1 1 1 0 1 1 0 0 0 0 0 0
PS 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
PG 11 0 1 0 0 0 0 0 0 1 1 1 0 0 0 0
PE 0 0 0 1 0 0
PC 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
MGDG 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DAG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
IL-2 secretion by mCD1d-restricted hybridomas in response to plate-bound mCD1d-IgGFc2a fusion protein and lipid antigens. A ª0º indicates
a mean of less than 50 pg/ml IL-2 was secreted, ª1º indicates 50±250 pg/ml, ª11º indicates 250±1000 pg/ml, ª111º indicates greater than
1000 pg/ml IL-2 secretion, and spaces left blank were not done in the experiment shown. Negative control wells contained neither fusion
protein nor antigen (No mCD1d). The mCD1d fusion protein was preincubated with buffer alone (No Ag), a-galactosylceramide (a-GalCer),
b-galactosylceramide (b-GalCer), unglycosylated ceramide (Cer), sphingomyelin (Sph), gangliotriosyl ceramide (aGM2), disialoganglioside
(GD1a), phosphatidic acid (PA), phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylglycerol (PG), phosphatidylethanolamine (PE),
phosphatidylcholine (PC), monogalactosyl diglyceride (MGDG), or diacyl glyceride (DAG). The results are compiled from six independent
representative experiments.
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Table 3. mCD1d-Restricted Hybridoma Responses to mCD1d-Transfected Tumor Cells
Invariant TCRa NKT Hybridomas Diverse TCR Hybridomas
24.8.A 24.7.C 24.9.E DN32D3 KT/7 KT/12 KT/22 KT/23 Vb/9 14S.6.A 14S.7.N 14S.10.C 14S.15.A VII68 VIII24 XV19 XV104
CD1/P815 111 111 0 0 0 0 0 0 0 111 1 1 111 11 11 1 1
CD1/EL4 111 111 111 1 0 0 0 1 0 111 1 0 111 11 1 0 1
CD1/RMA-S 111 11 0 0 0 0 0 0 0 11 1 11 11 1 1 1 0
CD1/A20 11 111 0 0 0 0 0 0 0 11 0 0 111 1 1 0 0
IL-2 secretion by mCD1d-restricted hybridomas in response to mCD1d-transfected tumor cell lines. The untransfected parental cell lines
induced little or no detectable IL-2 production by any of the hybridomas. A ª0º indicates a mean of less than 50 pg/ml IL-2 was secreted,
ª1º indicates 50±250 pg/ml, ª11º indicates 250±1000 pg/ml, and ª111º indicates greater than 1000 pg/ml IL-2 secretion. The results are
compiled from three independent representative experiments.
3). All of the diverse TCR hybridomas recognized at but whether these molecules represent self- or foreign
antigens, and whether the NKT cells that respond toleast two of the mCD1d transfectants (Table 3). Thus,
a-GalCer are the same as those that see phospholipids,although the diverse TCR hybridomas did not respond
has been unclear.strongly to any of the antigens screened in the mCD1d
Our finding that a lipid extract of RMA-S cells couldfusion protein stimulation assay, they could recognize
reconstitute the recognition of plate-bound mCD1d mol-mCD1d molecules expressed by different cell types.
ecules by an NKT cell hybridoma shows that self-lipidsAdditionally, hybridomas that shared specificity for
can serve as antigens for NKT cells. Further separationa-GalCer differed in their recognition of mCD1d ex-
of the lipids within the organic phase extract revealedpressed by distinct APCs.
specificity for fractions containing mainly polar glycolip-
ids and phospholipids, suggesting the 24.8.A hybridomaDiscussion
could recognize phospholipid antigens. This possibility
was supported by experiments showing that the 24.8.ABecause cell surface mCD1d molecules may be com-
hybridoma responded to certain purified and syntheticplexed with cellular lipids, it has been difficult to evalu-
phospholipids, including PI, PE, and PG, while PA, PS,ate the role of potential endogenous antigens in T cell
and PC did not reproducibly induce IL-2 production.recognition of mCD1d. The observation that a recombi-
Whether the failure of PA, PS, and PC to stimulate IL-2nant b2m-linked mCD1d-IgGFc2a fusion protein did not
release resulted from lack of recognition by the 24.8.Astimulate high levels of IL-2 production from mCD1d-
hybridoma or was due to inefficient binding of theserestricted T cell hybridomas allowed us to develop a
lipids to the fusion protein under the conditions of thesystem to analyze the contribution of lipid antigens to
plate stimulation assay is unclear. However, the 24.8.Arecognition of mCD1d molecules by T cells. Activation
hybridoma also did not respond to a-GalCer, which stim-of the hybridomas using plate-bound mCD1d fusion pro-
ulated other hybridomas when added to the mCD1dtein was dramatically enhanced after preincubation with
fusion protein, indicating that it can bind. Thus, the
certain lipids or lipid-containing cellular extracts. The
24.8.A hybridoma had specificity for three of the purified
response could be blocked by an anti-mCD1d mAb,
phospholipid antigens tested but not for a-GalCer.
showing that the mCD1d molecule was required for Unlike other hybridomas tested, the 24.8.A hybridoma
stimulation. Preincubation of a negative control protein had a variable amount of reactivity to the fusion protein
with the same lipids did not induce detectable IL-2 pro- that had not been pretreated with a lipid antigen. This
duction, indicating that the lipids did not have a nonspe- response could be due to recognition of the mCD1d
cific stimulatory effect. Hence, although other mecha- molecule itself, independent of a specific antigen. Alter-
nisms cannot be ruled out, together these results natively, the reactivity could result from recognition of
suggest that binding of certain lipid antigens to the an antigen that remained bound to the fusion protein
plate-bound mCD1d molecules permitted efficient rec- after purification (e.g., an antigen that derived from the
ognition of the mCD1d fusion protein by hybridomas CHO cells used to produce the fusion protein, or from
expressing cognate TCRs. the culture supernatant from which the fusion protein
Several investigations have now demonstrated that was purified). Hence, given their abundance in cells and
many NKT cells can respond to CD1d-mediated presen- in culture supernatants, one of the phospholipids shown
tation of the unusual acylphytosphingolipid a-GalCer here to stimulate the 24.8.A hybridoma could also be
(Kawano et al., 1997; Brossay et al., 1998; Burdin et responsible for its variable reactivity to the untreated
al., 1998; Spada et al., 1998). Additionally, glycosylated fusion protein.
forms of PI have been implicated as determinants recog- Eight of the NKT cell hybridomas tested responded
nized by murine CD1d-restricted NKT cells during proto- strongly to a-GalCer preincubated with the mCD1d fu-
zoal and mycobacterial infections, and PI-containing sion protein. Surprisingly, four of these a-GalCer reac-
compounds have been shown biochemically to be asso- tive hybridomas also had detectable reactivity to puri-
ciated with mCD1d molecules purified from transfected fied phospholipid antigens, suggesting that the cellular
human T2 cells (Joyce et al., 1998; Apostolou et al., antigens they recognize may be related lipids. The eight
1999; Schofield et al., 1999). Thus, sphingolipid and diverse TCR hybridomas tested did not respond repro-
phospholipid compounds can apparently bind CD1d ducibly to a-GalCer, but three also showed some re-
sponse to purified phospholipids. In all, responses toand function as antigens for CD1d-restricted NKT cells,
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PI, PE, or PG were detected for 8 of the 17 hybridomas sees a set of antigens that is distinct from those recog-
nized by mCD1d-restricted NKT cells, some of the di-tested. Thus, phospholipids may represent a major class
of self-antigens recognized by CD1d-restricted T cells, verse TCR hybridomas reacted to the same purified
phospholipids recognized by members of the NKT celland some of the T cells that recognize these antigens
may also respond to a-GalCer, while others do not. subset. Therefore, some of the diverse TCR mCD1d-
restricted T cell population may recognize similar self-The ability of the 24.8.A hybridoma to respond to
phospholipids but not a-GalCer is particularly interest- antigens to those recognized by mCD1d-restricted NKT
cells.ing with regard to its TCR gene usage. This hybridoma
possesses a cannonically rearranged Va14/Ja281 TCRa The observation that mCD1d-restricted T cells varied
in their recognition of different mCD1d-transfected tu-chain that is identical to those of the a-GalCer-reactive
NKT cell hybridomas, implying that it is the TCRb chain mor cells suggests that antigens presented by mCD1d
molecules differ according to the cell type. Given thewhich is responsible for its distinct antigen specificity.
Surprisingly, the 24.8.A hybridoma expresses TCR Vb broad expression of murine CD1d on cells of hematopoi-
etic origin, variation in antigen presentation among cells8.2, a Vb gene that is also used by most of the a-GalCer-
reactive NKT cell hybridomas we tested (Table 1). Thus, that express mCD1d could be a critical mechanism of
regulating mCD1d-restricted T cells (Brossay et al.,it is unlikely that the Vb of 24.8.A prevents recognition
of a-GalCer and seems instead that residues of the 1997; Mandal et al., 1998). Little is known about the
factors that affect endogenous lipid antigen presenta-CDR3 loop encoded by the D segment, Jb, or by N-region
addition may be critical in conferring its antigenic speci- tion by mCD1d molecules, although variations in antigen
presentation could arise from differences among APCsficity. Hence, despite their invariant TCRa chains and
limited TCR Vb gene usage, the diverse TCRb VDJ junc- in expression, trafficking, processing, or mCD1d loading
of antigens.tional regions of CD1d-restricted NKT cells may result
in multiple different antigenic specificities within this T Antigen recognition in our mCD1d fusion protein pre-
sentation assay could occur after preincubation at pHcell subset.
The potential for heterogeneous antigen specificities 7.2 but was significantly enhanced by preincubation at
pH 4.0. Therefore, while acidic pH is not required, itmay explain our surprising finding that NKT cell hybrid-
omas which responded similarly to a-GalCer presenta- may facilitate lipid binding to the fusion protein. This
observation might help to explain apparently conflictingtion by the plate-bound mCD1d fusion protein varied in
their patterns of recognition of a panel of four mCD1d- results regarding a-GalCer presentation by APCs. Bur-
din et al. (1998) found that a-GalCer could be presentedtransfected tumor cells. One a-GalCer-reactive hybrid-
oma recognized all of the transfectants well, while three in the absence of endosomal trafficking and acidifica-
tion, while in the experiments of Kawano et al. (1997)of the hybridomas only responded to one of the transfec-
tants, and the remaining four a-GalCer-specific hybrid- and Spada et al. (1998) these elements of cellular antigen
processing appeared necessary for a-GalCer presenta-omas did not recognize any of the transfectants. This
result suggests that the endogenous cellular antigen tion to NKT cells. Our results suggest that a-GalCer
binding to mCD1d at the cell surface at neutral pH isrecognized by these hybridomas is not a-GalCer or a
single analog, since in that case recognition of the mCD1d- possible, but that binding may be favored in endocytic
vesicles that have an acidic pH. In contrast, recognitiontransfected cells should correlate with the a-GalCer reac-
tivity observed in the plate stimulation assay. Instead, of cell surface mCD1d by diverse TCR hybridomas did
not appear to require endosomal localization (Chiu et al.,based on the three patterns of reactivity with the mCD1d
transfectants, there must be at least three different anti- 1999). Thus, intracellular trafficking of CD1d molecules
may play a critical role in determining the antigens pre-genic specificities among the eight a-GalCer-reactive
NKT cell hybridomas tested. The a-GalCer antigen might sented by cells that express CD1d.
The in vitro mCD1d-specific antigen recognition sys-stimulate many NKT cells because it possesses a com-
mon determinant of some diverse set of antigens, or it tem described here should prove useful in the isolation
and identification of endogenous cellular antigens rec-may function similarly to a superantigen and activate a
large fraction of CD1d-restricted NKT cells, regardless ognized by CD1-restricted T cells. Analysis of biochemi-
cally fractionated cellular lipids for their ability to stimu-of their other antigenic specificities. A recent analysis
late mCD1d-restricted hybridomas after addition to theby Kawano et al. (1999) identifies an amino acid motif
mCD1d fusion protein could provide a means of identi-in the CDR3 region of TCRb chains of human CD1d-
fying physiological antigens presented by normal orrestricted NKT cells that responded to selection by
neoplastic cells. Identification of the natural antigensa-GalCer, indicating that this antigen preferentially stim-
recognized by mCD1d-restricted T cells will be criticalulates a subset of the CD1d-restricted T cells.
to our future understanding of the role of these cells inBased on their diverse TCR structures, non-NKT lin-
disease processes such as autoimmunity and cancer.eage mCD1d-restricted hybridomas are thought to see
a heterogeneous group of antigens (Cardell et al., 1995;
Behar et al., 1999). The diverse TCR mCD1d-restricted Experimental Procedures
hybridomas tested in this analysis could recognize mul-
Hybridomastiple mCD1d-transfected cell lines, suggesting that they
The CD1d-restricted T cell clones 24.7, 24.8, 24.9 (NKT cell) andrecognize broadly distributed cellular antigens. In con-
14S.6, 14S.7, 14S.10, and 14S.15 (diverse TCRs) were all derived
trast to most of the NKT hybridomas, the diverse TCR from spleen of wild-type C57BL/6 mice, as described previously
hybridomas did not respond strongly to a-GalCer. While (Behar et al., 1999). To generate T cell hybridomas, the activated
T cells were fused to the aminopterin-sensitive BW5147 abTCR2this result suggests that the diverse TCR population
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thymoma cell line using PEG1500, and hybrids were selected in HAT column (Amersham-Pharmacia Biotech) and eluted with 50 mM so-
dium acetate buffer at pH 4.3, followed by immediate neutralizationmedium (Life Technologies). Resulting TT hybridomas were tested
for recognition of RMA-S cells transfected with mCD1D1 compared by addition of 1/10 vol of a 1 M Tris buffer at pH 8.8. Subsequent
analysis of the protein A eluate by size exclusion chromatographyto untransfected RMA-S cells, as described below. Hybridomas that
demonstrated specific recognition of mCD1d were further sub- using a Superose 6 column (Amersham-Pharmacia) revealed a single
peak eluting slightly earlier than a polyclonal IgG standard, as ex-cloned by limiting dilution. The hybridomas are distinguished from
the original T cell clones by the addition of a letter to their names. pected for a homodimeric fusion protein complex. Analysis by re-
ducing and nonreducing SDS-PAGE demonstrated single bands atThe KT/7, KT/12, KT/22, KT/23, and Vb/9 NKT cell hybridomas were
derived from NK1.11 T cells enriched from spleen of C57BL/6 mice the expected molecular weights of approximately 100 kDa and 200
kDa, respectively.by depletion of CD81 T cells, naive T cells, and B cells by mAbs
(anti-B220, CD8, and CD62L, or anti-CD8a, CD8b, and Mel14) bound
to magnetic microbeads or to plastic. The purified cells were stimu- Cellular Extracts and Fractionation
lated either by the anti-CD3 KT3 mAb (KT/7, KT/12, KT/22, KT/23) Cellular lipid was extracted from RMA-S and S49 murine T lym-
or by an anti-Vb8.2 mAb (Vb/9) and addition of IL-2 or IL-2 and IL-7. phoma cells using the method of Folch et al. (1956), with modifica-
After 4±5 days of culture, the cells were fused with BW5147 thymoma tions as described by Hamilton and Hamilton (Hamilton et al., 1992).
cells. The VII68, VIII24, XV19, and XV104 diverse TCR hybridomas Briefly, 1 g of pelleted cells was mixed with 20 ml of a 2:1 v/v
were generated from CD41 T cells from class IIo mice, as described chloroform:methanol solution (C:M), then homogenized and incu-
previously (Cardell et al., 1995). The DN32D3 hybridoma was derived bated at room temperature for 1 hr. The mixture was centrifuged to
as described (Lantz and Bendelac, 1994). remove insoluble material, and the supernatant saved. A 1/5 vol of
sterile dH2O was added to the C:M supernatant and the mixture was
shaken until an emulsion formed, then incubated 24 hr at roomGeneration of mCD1d Fusion Protein
temperature to allow phase separation into an organic fraction, anA soluble murine CD1d fusion protein covalently linked to human
aqueous fraction, and the interface. For analysis using the mCD1db2m at the N terminus by a glycine-serine (Gly-Ser) spacer peptide
fusion protein assay, the aqueous and interface fractions were ly-and at the C terminus to the Fc portion of murine IgG2a by another
ophilized, and the organic fraction was dried under a stream ofGly-Ser spacer peptide, was constructed as follows. All synthetic
nitrogen. The samples were then quantified by weight and resus-oligonucleotides were commercially obtained, (Operon Technolo-
pended in dimethyl sulfoxide (DMSO). The organic phase was fur-gies). A cDNA of the full-length coding sequence of mCD1D1 was
ther fractionated by dissolving 35 mg of dried sample in chloroformused as template DNA for PCR amplification. PCR primers were
and applying it to a silica column (400 mesh silicic acid; Selectodesigned to create a truncated mCD1D1 gene, which eliminates the
Scientific). Lipids of increasing polarity were eluted from the columncytoplasmic, transmembrane, and leader peptide sequences. The
using a stepwise gradient of chloroform, acetone, and methanol.59 primer oligonucleotide sequence, containing a SpeI restriction
The resulting fractions were dried, quantitated, and solubilized insite, was 59-GCGCGGACTAGTTCTGAAGCCCAGCAAAAGAATTA
C:M, then dried down and resuspended in DMSO prior to use.CACC-39, and the 39 primer sequence, containing a NotI restriction
site, was 59-TGCTTGGCGGCCGCTCCAGTAGAGGATGATATCCTG
TCC-39. A cDNA fragment encoding human b2m fused to the Gly- Glycolipid Antigens
Ser linker was generated by PCR, using as a template a cDNA The following antigens were commercially obtained (Matreya Corpo-
construct encoding a human b2m-linked single chain CD1a molecule. ration): purified bovine brain sphingomyelin (Sph), purified bovine
The 59 primer sequence containing an XhoI site was 59-GCGCGGC brain disialoganglioside (GD1a), purified bovine brain gangliotriosyl
TCGAGCATGTCTCGCTCCGTGGCCTTAGC-39, and the 39 primer ceramide (aGM2), purified plant monogalactosyl diglyceride (MGDG),
sequence containing an XbaI restriction site was 59-CGGCTCTA purified bovine phosphatidylserine (PS), purified soybean phospha-
GATCCACCTCCAGAACCGGATCCACCTG-39. The PCR products tidylinositol (PI), synthetic dipalmitoyl phosphatidylinositol 3-phos-
were digested with the appropriate restriction enzymes, ligated and phate (PI3-P), synthetic dipalmitoyl phosphatidylinositol bis-3,4-
subcloned, and the fragment containing b2m linked to mCD1d was phosphate (PI3,4-P2), synthetic dipalmitoyl phosphatidylinositol
excised by digestion with XhoI and NotI. This fragment was linked tris-3,4,5-phosphate (PI3,4,5-P3), synthetic distearoyl phosphatidyl-
to a cDNA fragment encoding the hinge, CH2, and CH3 regions of choline (PC), purified distearoyl phosphatidylethanolamine (PE),
murine IgG2a using a synthesized DNA fragment encoding a 14±amino synthetic dipalmitoyl phosphatidylglycerol (PG), and synthetic dipal-
acid Gly-Ser spacer peptide sequence (SGPGGSGGSGGSGG), made mitoyl phosphatidic acid (PA). Palmitic acid (palmitate), free inositol,
from the following complementary oligonucleotides: 59-GGCCCG and dipalmitin diacylglycerol (DAG) were acquired from Sigma. The
GGAGGTTCTGGAGGTTCAGGAGGTTCTGGAGGG-39 and 59-GATC synthetic a- and b-galactosylceramide (a-GalCer, b-GalCer) and
CCCTCCAGAACCTCCTGAACCTCCAGAACCTCCCG-39. The 3 cDNA unglycosylated ceramide (Cer) were produced synthetically as pre-
fragments were ligated and subcloned into the pBluescript SK vec- viously described (Kawano et al., 1997). The antigens were dissolved
tor (Stratagene). The resulting construct was fully sequenced with at a stock concentration of 100 or 200 mg/ml in DMSO and were
M13 reverse and T7 outside primers to ensure that no coding muta- sonicated in a 378C water bath for 10 min prior to use.
tions were present, then excised by restriction digestion and sub-
cloned into the pBJ1-neo expression vector for transfection (Lin et Plate-Bound mCD1d Fusion Protein Hybridoma
al., 1990). Stimulation Assays
To test for recognition of the mCD1d fusion protein and purified or
synthetic antigens, 96-well protein A±coated plates (Pierce Chemi-Production and Purification of mCD1d Fusion Protein
Chinese hamster ovary (CHO) cells were transfected with the PBJ1- cal Company) were incubated with 400±600 ng/well of the fusion
protein or a negative control IgG2a antibody, RPC5.4 or UPC10, inneo vector containing the b2m-mCD1d-Fc2a cDNA construct by elec-
troporation, then selected for G418 drug resistance and subcloned PBS at pH 7.2. Lipid antigens were diluted into PBS and added
where specified at the indicated molar ratio of antigen to fusionby limiting dilution to isolate stably transfected cells with high
protein expression levels. Culture supernatants were tested for protein (when not specified the ratio was 40:1). Protein A plates
containing the fusion protein and antigen were incubated 24±48 hrthe presence of the mCD1d fusion protein by a standard double
antibody sandwich ELISA using the 1B1 anti-mCD1d monoclonal at 378C, then washed three times with 200 ml/well sterile PBS (pH
7.2) and two times with 200 ml/well sterile culture medium (containingantibody (PharMingen) as a capture reagent and a biotinylated poly-
clonal rabbit anti-human b2m anti-serum (DAKO, Glostrup, Den- RPMI supplemented with L-glutamine and penicillin/streptomycin
[Life Technologies] and 10% bovine calf serum [Hyclone Labora-mark), followed by a streptavidin-alkaline phosphatase conjugate
(Zymed) or an anti-murine IgG2a antibody conjugated directly to tories]). For assays in which the PI was phospholipase treated, it
was first diluted into 0.01 M Tris, 0.15 M NaCl (pH 7.5) containing 0.25alkaline phosphatase (Zymed), as the detection reagent. The fusion
protein was detectable by both methods, indicating that the mCD1d U PI-specific phospholipase C or 0.5 U phospholipase D (Sigma) and
incubated 30 min at room temperature, then added to the proteinwas complexed with both human b2m and murine IgG2a Fc. The CD1d
fusion protein was purified by passage over a protein A Sepharose A plates as described above. For assays in which the pH was varied
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during antigen incubation with the fusion protein, the fusion protein Bendelac, A., Killeen, N., Littman, D.R., and Schwartz, R.H. (1994).
A subset of CD41 thymocytes selected by MHC class I molecules.and a-GalCer were diluted into a 20 mM citrate/phosphate buffer
of the specified pH, which contained 0.15 M NaCl, and after incuba- Science 263, 1774±1778.
tion the samples were neutralized by addition of 1 M Tris (pH 7.5). Bendelac, A., Lantz, O., Quimby, M.E., Yewdell, J.W., Bennink, J.R.,
Hybridoma cells were added to fusion protein/antigen-treated plates and Brutkiewicz, R.R. (1995). CD1 recognition by mouse NK11 T
at a concentration of 1 3 105 cells/well, in a total volume of 150 ml/ lymphocytes. Science 268, 863±865.
well. Assays were performed using 2±6 replicate wells. In some Brossay, L., Jullien, D., Cardell, S., Sydora, B.C., Burdin, N., Modlin,
assays, an anti-mCD1d blocking antibody (19G11) was included at R.L., and Kronenberg, M. (1997). Mouse CD1 is mainly expressed
a final concentration of 20 mg/ml. The plates were incubated at 378C on hemopoietic-derived cells. J. Immunol. 159, 1216±1224.
for 16±20hr, and culture supernatants were withdrawn for analysis.
Brossay, L., Tangri, S., Bix, M., Cardell, S., Locksley, R., and Kro-Each experiment was performed at least three times.
nenberg, M. (1998). Mouse CD1-autoreactive T cells have diverse
patterns of reactivity to CD11 targets. J. Immunol. 160, 3681±3688.Generation of mCD1d APC Transfectants and mCD1d
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S.T., Grusby, M.J.,Recognition Assay
Gui, M., Taniguchi, M., Hayakawa, K., and Kronenberg, M. (1998).CD1D1-transfected RMA-S cells were derived as described pre-
Selective ability of mouse CD1 to present glycolipids: alpha-galacto-viously (Behar et al., 1999). A similar procedure was used to transfect
sylceramide specifically stimulates V alpha 141 NK T lymphocytes.the EL4, A20, and P815 cell lines. Briefly, the cells were transfected
J. Immunol. 161, 3271±3281.by electroporation with the pSRa-neo expression vector containing
mCD1D1 cDNA and subjected to G418 drug selection to obtain Cardell, S., Tangri, S., Chan, S., Kronenberg, M., Benoist, C., and
stably transfected lines. Drug-resistant cells were stained using the Mathis, D. (1995). CD1-restricted CD41 T cells in major histocom-
19G11 or 1B1 rat anti-mCD1d mAbs (graciously provided by Dr. patibility complex class II deficient mice. J. Exp. Med. 182, 993±1004.
Albert Bendelac, Princeton University, and Dr. Laurent Brossay, Chiu, Y.H., Jayawardena, J., Weiss, A., Lee, D., Park, S.H., Dautry-
UCLA, respectively) and analyzed by flow cytometry. In some cases Varsat, A., and Bendelac, A. (1999). Distinct subsets of CD1d-
the cultures were sorted using a FACsort (Becton Dickinson) to restricted T cells recognize self-antigens loaded in different cellular
obtain cells expressing high levels of mCD1d, then cloned by limiting compartments. J. Exp. Med. 189, 103±110.
dilution. Hybridomas were tested for IL-2 production in the presence
Couedel, C., Peyrat, M.A., Brossay, L., Koezuka, Y., Porcelli, S.A.,of the mCD1d-transfected compared to the untransfected parental
Davodeau, F., and Bonneville, M. (1998). Diverse CD1d-restrictedcell lines. Hybridomas and APCs were added at a concentration of
reactivity patterns of human T cells bearing ªinvariantº AV24BV111 3 105 cells/well each, in a total volume of 150 ml/well, and incu-
TCR. Eur. J. Immunol. 28, 4391±4397.bated as described above.
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko,
Y., Koseki, H., Kanno, M., and Taniguchi, M. (1997). RequirementDetection of IL-2 Secretion
for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Sci-IL-2 secreted in the hybridoma stimulation assays was quantitated
ence 278, 1623±1626.in a double antibody sandwich ELISA, by comparison to a standard
curve of purified murine IL-2 (PharMingen). Hybridoma plate stimula- Folch, J., Lees, M., and Sloane-Stanley, G.H. (1956). A simple
method for the isolation and purification of total lipides from animaltion supernatants (used either neat or diluted) and serially diluted
IL-2 standards were added to 96-well ELISA plates coated with a tissues. J. Biol. Chem. 226, 497±509.
rat anti-mouse IL-2 capture antibody (PharMingen). IL-2 was de- Hamilton, S., Hamilton, R.J., and Sewell, P.A. (1992). Extraction of
tected by addition of a biotinylated rat anti-mouse IL-2 antibody, lipids and derivative formation. In Lipid Analysis: a Practical Ap-
followed by addition of a streptavidin-alkaline phophatase conju- proach (Oxford: IRL Press at Oxford University).
gate and a chromogenic substrate. The picograms per milliliter of Joyce, S., Woods, A.S., Yewdell, J.W., Bennink, J.R., De Silva, A.D.,
IL-2 present in the hybridoma supernatants was quantitated by lin- Boesteanu, A., Balk, S.P., Cotter, R.J., and Brutkiewicz, R.R. (1998).
ear regression of the IL-2 standard curve. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinosi-
tol. Science 279, 1541±1544.
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